Magas vérnyomás: vizsgálatok itt: Törökország
6 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Adana, Adapazarı, Altındağ, Ankara, Antalya, Haliliye, Kahramanmaraş, Kayseri, Kocaeli, Şahinbey
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - No phaseTaking peopleAnticipated Stigma, Illness Identity, and Quality of Life in Male Hypogonadism
- Where
- Bingoel, Malatya
- Életkor
- 18 év and over
- People
- 90
- Run by
- Hacettepe University
See details and how to joinNCT07752511 - No phaseCsak meghívásosAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Where
- Adana, Ankara, Istanbul
- Életkor
- 0 Minutes to 2 hét
- People
- 8000 worldwide
- Run by
- Indiana University
See details and how to joinNCT06823115 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Edirne, Istanbul, Izmir, Kayseri, Malatya, Zonguldak
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisTaking peopleZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Where
- Eskişehir, Istanbul, Izmir, Kocaeli, Konya, Muratpaşa, Sivas
- Életkor
- 18 év and over
- People
- 11 000 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07181109 · EU 2025-522960-34-00 - 3. fázisCsak meghívásosA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Adana, Ankara, Bursa, Eskişehir, Istanbul, Izmir, Mersin
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00